High red cell distribution width as a prognostic indicator in heart failure
This meta-analysis confirms that high RDW is a robust predictor of adverse outcomes in patients with HF, highlighting its potential utility as a simple, cost-effective biomarker for risk stratification. Future research should focus on elucidating the mechanisms underlying this association and exploring the potential benefits of RDW-guided therapeutic strategies in HF management.
Authors
- VIBHOR AHLUWALIA
- Azra Kothawala (ORCID: https://orcid.org/0000-0001-6830-3591)
- Sidhartha Gautam Senapati (ORCID: https://orcid.org/0000-0002-4031-574X)
- Rupak Desai
Institutions
- Texas Tech University (US)
- Outcomes Research Consortium (US)
- The University of Texas at El Paso (US)
- Nazareth Hospital (US)
- Jawaharlal Nehru Medical College (IN)
- Health Economics and Outcomes Research (United Kingdom) (GB)
Publication Details
- Journal
- World Journal of Methodology
- Published
- 2026-02-10
- DOI
- https://doi.org/10.5662/wjm.v16.i1.108611
- Primary Topic
- Inflammatory Biomarkers in Disease Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00